Olema Pharmaceuticals inc logo

Olema Pharmaceuticals inc

$ 4.55 -0.32 (-6.57%) 11:08 PM EST
P/E:
At Loss
P/B:
0.84
Market Cap:
$ 184.07M
Enterprise V:
$ -35.70M
Volume:
77.42K
Avg Vol (2M):
170.80K
Volume:
77.42K
Market Cap $:
184.07M
PE Ratio:
At Loss
Avg Vol (2-Month):
170.80K
Enterprise Value $:
-35.70M
PB Ratio:
0.84

Business Description

Description
Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250.
Name Current Vs Industry Vs History
Cash-To-Debt 78.66
Equity-to-Asset 0.94
Debt-to-Equity 0.01
Debt-to-EBITDA -0.03
Interest Coverage N/A
N/A
N/A
Piotroski F-Score 2/9
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History
3-Year EBITDA Growth Rate -127.2
3-Year EPS without NRI Growth Rate -80.9
3-Year FCF Growth Rate -104.8

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 33.64
9-Day RSI 55
14-Day RSI 62.42
6-1 Month Momentum % -50.75
12-1 Month Momentum % -55.1

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 17.93
Quick Ratio 17.93
Cash Ratio 17.73

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -41.3
Name Current Vs Industry Vs History
ROE % -38.42
ROA % -36.7
ROIC % -1101.89
ROC (Joel Greenblatt) % -2696.68
ROCE % -38.52